Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
-
Cognos Therapeutics Announces Formation of Industry Advisory Board
-
ARKO Corp. Reports Second Quarter 2024 Results
-
Synchronoss Technologies Reports Second Quarter 2024 Results
-
Pennant Reports Second Quarter 2024 Results
-
Evercommerce Names Ryan Siurek as Chief Financial Officer
-
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024
-
Arogo Capital Acquisition Corp. Announces Receipt of and Appeals Nasdaq Delisting Determination
-
Rapid7 Announces Second Quarter 2024 Financial Results
-
Inter Parfums, Inc. Reports Record 2024 Second Quarter Results
-
Brilliant Earth Announces Participation in Sidoti Micro Cap Conference
-
HF Foods Reports Second Quarter 2024 Financial Results
-
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results
-
Comscore Reports Second Quarter 2024 Results
-
OraSure Reports Q2 ’24 Revenue of $54.3 Million
-
BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024
-
EverCommerce Announces Second Quarter 2024 Financial Results
-
Nasdaq Chair and Chief Executive Officer Adena Friedman to Present at the Oppenheimer 27th Annual Technology, Internet & Communications Conference
-
Veeco Reports Second Quarter 2024 Financial Results
-
GigaCloud Technology Inc Announces Second Quarter and Six Months Ended June 30, 2024 Financial Results
-
Latham Group, Inc. Reports Second Quarter 2024 Financial Results
-
MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance
-
Treace Medical Concepts Reports Second Quarter 2024 Financial Results
-
Flywire Acquires Invoiced to Bolster its Global B2B Payment Network with Award-winning Accounts Receivable SaaS Platform
-
SAI.TECH Announces Adjournment of Annual General Meeting
-
Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Immuneering Reports Second Quarter 2024 Financial Results and Provides Business Updates
-
Climb Global Solutions Reports Second Quarter 2024 Results and Announces Acquisition of Douglas Stewart Software & Services, LLC
-
Latham Group Acquires Coverstar Central - Latham’s Exclusive Automatic Safety Cover Dealer in 29 States
-
Nanox to Report Second Quarter and Financial Results on August 20, 2024
-
Consumer Portfolio Services to Present at the 2024 Gateway Conference on September 4
-
Freshworks to Participate in the Oppenheimer 27th Annual Technology, Internet & Communications Conference
-
TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
AvePoint to Participate in Upcoming Investor Conferences
-
Adeia Announces Second Quarter 2024 Financial Results
-
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
-
Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Progyny, Inc. Announces Second Quarter 2024 Results
-
Inspire Medical Systems, Inc. Announces Second Quarter 2024 Financial Results and Updates 2024 Outlook
-
Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Vireo Growth Inc. Announces Second Quarter 2024 Results
-
Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program
-
MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
-
Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024
-
Sunrun Reports Second Quarter 2024 Financial Results
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results
-
EMCORE Reports Fiscal 2024 Third Quarter Results
-
Nanophase Reports Record Second Quarter Revenue and Profit
-
Standard BioTools to Participate in Upcoming Investor Conferences

